Todos Medical Ltd (OTCQB:TOMDF) announced the commercial launch of its proprietary 3CL protease inhibitor dietary supplement Tollovid at The Alchemist’s Kitchen in the SoHo district in New York.
Tollovid, a mix of botanical extracts, is being targeted to support healthy immune function against circulating coronaviruses, Todos said in a statement Monday.
Tollovid’s mechanism of action is to inhibit the activity of the 3CL protease, a key protease required for the intracellular replication of coronaviruses. Tollovid was granted a Certificate of Free Sale by the US Food and Drug Administration in August 2020, allowing its commercial sale anywhere in the US.
READ: Todos Medical sees its November 2020 sales surge 269% month-over-month as COVID-19 testing demand rises
Israel-based Todos recently announced positive in vitro data from its joint venture partner NLC Pharma, demonstrating Tollovid’s potency in inhibiting the 3CL protease, as well as significant positive feedback from over 1,000 clients in Israel who have purchased Tollovid for use against circulating coronaviruses.
“We have spent the last several months looking for new products that could assist our customers in boosting healthy immune function in the face of circulating coronaviruses,” said Lou Sagar, CEO of The Alchemist’s Kitchen. “We believe that Tollovid certainly has a very attractive profile that, in combination with standard immune-boosting dietary supplements such as vitamin C and vitamin D, may add a layer of protection in the event an individual has been recently exposed or is suffering from an actively circulating coronavirus.”
Sager added: “We must carefully follow the science as it relates to circulating coronaviruses, and we feel comfortable that Tollovid may be helpful for our community as we head into what some public health officials have described as the worst public health crisis in our nation’s history.”
The Alchemist's Kitchen is a plant-based wellness brand dedicated to the education of consumers about the potential benefits of botanical medicines and herbal remedies. It develops and markets proprietary formulations via retail and online channels of distribution.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham